New analysis boosts drug's prostate cancer value

WASHINGTON (Reuters) - A new analysis of data from a key prostate cancer study has strengthened the view that a drug that is now sold as a generic may be a valuable weapon to prevent prostate cancer, researchers said on Monday.

Continue to New analysis boosts drug's prostate cancer value on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz